Day: September 28, 2023
Latest edition of Haleon Pain Index finds half (49%) of people in pain feel stigmatised[1][2]
42% regularly feel lonely due to their pain, and one third feel serious loneliness (based on UCLA loneliness scale)[3]
32% of people living in pain fear they will be judged
Women, people of colour and the LGBQ+ community are worst affected
Gen Z more likely to feel unheard than Baby BoomersLONDON, Sept. 28, 2023 (GLOBE NEWSWIRE) — A new study of 18,097 people across 18 countries has discovered that society has grown less tolerant of people in pain, despite the effects of COVID-19 boosting global health awareness.
The fifth edition of the Haleon Pain Index (HPI)[1], conducted by consumer health company Haleon, suggests that attitudes towards pain in post-pandemic society are now more judgemental and less tolerant, with half (49%) of...
Economist Impact Research for Temenos Shows Banking is Becoming Byte-Sized with Rise of Embedded Finance
Written by Customer Service on . Posted in Public Companies.
Banks must harness emerging technologies and create or participate in digital ecosystems to remain at the center of the banking universe, according to the report
GENEVA, Switzerland, Sept. 28, 2023 (GLOBE NEWSWIRE) — Banks must harness disruptive technologies and create their own or actively participate in digital ecosystems to remain at the heart of the banking universe, according to a global Economist Impact study, commissioned by Temenos, which surveyed 300 banks across the globe.
The report, “Byte-sized banking: Can banks create a true ecosystem with embedded finance?” finds that payment companies, technology and e-commerce disruptors are competing against banks with embedded finance solutions. Coupled with consumers’ growing expectations for better, more personalized products and services, this is forcing banks to assess the...
Share Buyback Transaction Details September 21 – September 27, 2023
Written by Customer Service on . Posted in Public Companies.
Share Buyback Transaction Details September 21 – September 27, 2023
September 28, 2023 – Wolters Kluwer (Euronext: WKL), a global leading provider of expert solutions, insights and services for professionals, today reports that it has repurchased 215,701 of its own ordinary shares in the period from September 21, 2023, up to and including September 27, 2023, for €24.6 million and at an average share price of €114.09.
These repurchases are part of the share buyback program announced on February 22, 2023, under which we intend to repurchase shares for up to €1 billion during 2023.
The cumulative amounts repurchased to date under this year’s buyback program are as follows:
Share Buyback 2023Period
Cumulative shares repurchased in period
Total consideration(€ million)
Average share price(€)2023 to date...
Result of the auction of treasury bills on 28 September 2023
Written by Customer Service on . Posted in Public Companies.
Bids, sales, stop-rates and prices are presented in the table below: ISIN
Bid Mill. kr. (nominal)
Sale
Stop-rate (per cent)
Pro-rata
Price98 19153 DKT 01/12/23 IV
1,100
100
3.540
100 %
99.413598 19237 DKT 01/03/24 I
3,700
2,500
3.545
100 %
98.5349Total
4,800
2,600
The sale will settle 2 October 2023
Harpoon Therapeutics Presents HPN217 Interim Phase 1 Data at the IMS Annual Meeting
Written by Customer Service on . Posted in Public Companies.
Target dose of 12 mg demonstrates robust early activity and manageable tolerability profile:– 63% ORR, 16% cytokine release syndrome (CRS), No ICANS –
Phase 1 data set, including recommended Phase 2 dose(s) (RP2D), to be presented by the end of 2023
SOUTH SAN FRANCISCO, Calif., Sept. 28, 2023 (GLOBE NEWSWIRE) — Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing novel T cell engagers, today announced the presentation of interim data for the 2.15 to 12 mg target dose cohorts from its Phase 1 clinical trial evaluating single-agent HPN217 in relapsed/refractory multiple myeloma (RRMM). HPN217 targets B-cell maturation antigen (BCMA) and is based on Harpoon’s proprietary Tri-specific T cell Activating Construct (TriTAC®) platform designed to recruit a patient’s immune cells to kill tumor cells....
Advantest Receives PCI Express® Gen 5 Certification for MPT3000 Solid-State Drive Test Systems
Written by Customer Service on . Posted in Public Companies.
MPT3000 Is World’s First SSD Production Tester to Be Certified by PCI-SIG® for High-Speed PCIe® Gen 5 Compliance Testing
TOKYO, Sept. 28, 2023 (GLOBE NEWSWIRE) — Leading semiconductor test equipment supplier Advantest Corporation (TSE: 6857) today announced that its MPT3000 solid-state drive (SSD) test system has become the world’s first SSD production tester to be certified by PCI-SIG® for high-speed compliance testing of PCI Express® (PCIe®) fifth-generation (Gen 5 or 5.0) devices. Advantest completed the rigorous testing process and was awarded certification in August 2023.
Previously approved for PCIe 4.0 compliance testing, the MPT3000 is now also approved for official PCIe 5.0 compliance and certification testing. The PCIe 5.0 certification was awarded specifically to two key products in the MPT3000 family: the MPT3000ES3...
Hi-View Exploration Update on the Golden Stranger BC Property
Written by Customer Service on . Posted in Public Companies.
Figure 1. Close Up of Golden Stranger Claim Group SamplesFigure 1. Close Up of Golden Stranger Claim Group SamplesTHIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES
VANCOUVER, British Columbia, Sept. 28, 2023 (GLOBE NEWSWIRE) — Hi-View Resources Inc. (‘Hi-View’) (CSE: HVW; FSE: B63) reports that APEX Geoscience Ltd. has completed a soil and rock sampling program of its BC Golden Stranger property, located in the Toodoggone region of northern British Columbia.
The sampling program targeted select areas of the Golden Stranger mineralized zone with a modern soil sampling program, covering portions of the Toodoggone volcanics including the important Metsantan members that hosts the Golden Strange zone. The sampling program also identified some new points of...
Virtune introduces an innovative staked Ethereum ETP into the German market
Written by Customer Service on . Posted in Public Companies.
Stuttgart, 28th of September 2023 – Virtune, a regulated crypto ETP (“Exchange Traded Product”) issuer, based in Stockholm Sweden, is pleased to announce the admission of the Virtune Staked Ethereum ETP into the German market on Boerse Stuttgart.
The crypto market has experienced a considerable slow down in the past months, marked by outflows from ETPs in Europe. Nevertheless, Virtune has witnessed strong traction in the Nordic markets with continuous steady inflows, making this expansion a natural progression for the company.
Virtune Staked Ethereum ETP is a 100% physically backed ETP with Coinbase serving as its crypto custodian. This ETP offers investors exposure to Ethereum coupled with staking yield enhancements, which can generate an additional return on its Ethereum exposure.
Virtune, a registered financial institution...
Capgemini boosts its semiconductor capabilities in Europe with acquisition of HDL Design House
Written by Customer Service on . Posted in Mergers And Acquisitions.
Media relations:Sam ConnattyTel.: +44 (0)370 904 3601sam.connatty@capgemini.com
Investor relations:Vincent BiraudTel.: +33 1 47 54 50 87vincent.biraud@capgemini.com
Capgemini boosts its semiconductor capabilities in Europe with acquisition of HDL Design House
Paris, September 28 – Capgemini announces the acquisition of HDL Design House, a leading independent provider of silicon design and verification services in Europe. The acquisition will extend the Group’s global silicon engineering capabilities that are already among the world’s largest. It reinforces silicon services as a key enabler of the intelligent industry revolution where the Group is a leader. The transaction closed on September 27.
Founded in 2001 and headquartered in Belgrade (Serbia), HDL Design House comprises approximately 300 highly skilled engineers with substantial...
Novozymes launches new biosolution to redefine the plant-based meat experience by enhancing texture and encouraging more consumers to choose plant-based alternatives
Written by Customer Service on . Posted in Public Companies.
Novozymes is excited to offer Vertera® ProBite as a game-changing solution to the plant-based meat industry, opening up new possibilities to create today’s and tomorrow’s plant-based meat products with advanced texture and consumer-friendly labels. The new product is a part of Novozymes’ commitment to driving innovation in biosolutions and promoting sustainable food choices.
Copenhagen – September 28: Today marks an important milestone in the evolution of plant-based meat innovation with the launch of Vertera® ProBite, a solution set to advance the plant-based meat industry by changing the need for manufacturers’ use of unwanted texturizers to a natural alternative. Developed by global biosolutions provider, Novozymes, Vertera® ProBite will address and resolve the primary consumer concerns of texture and long ingredient lists...